China has approved human trials of an experimental SARS vaccine, and 30 people have already volunteered to be the first test subjects, state media reported Monday. Researchers cautioned that the government’s approval of what it called the first phase of human trials doesn’t mean the vaccine can be produced for widespread use anytime soon, a report on China Central Television said.
